Clinical trial results Sarcoidosis-associated small fiber neuropathy: In a blinded, placebo-controlled trial, 28 days of daily subcutaneous ARA-290 administration in patients with documented small nerve fiber loss produced significant improvements
Light technical work, no contact but moving and training
For individuals concerned about their alcohol drinking and its potential impact on health, including the risk of alcohol nerve damage, understanding the role of metabolism in determining BAC can be crucial
Over time this has led to research using T1 in numerous conditions spanning everything from immune deficiency, chronic infection, oncology, healthy aging and immune recovery
Dermapen or dermaroller (0.5-1.0mm needle depth)
Disclaimer: This blog is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease